Atlas Trials

Radscopal Radiotherapy Plus Immunotherapy for Chemotherapy-Ineligible Patients With Newly Diagnosed Metastatic Nasopharyngeal Cancer: A Single-Center, Open-Label, Phase II Study

Clinical trial NCT07756190 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07756190
Sponsor
Sun Yat-sen University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Nasopharyngeal Carcinoma (NPC)Metastatic Nasopharyngeal Carcinoma
Start date
2026-09-01
Primary completion
2029-12-30
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.